The association between resting metabolic rate and blood groups in overweight and obesity

Aim: Obesity is characterized as increase of fat tissue due to energy imbalance in the body. Resting metabolic rate shows the energy required for vital functions at resting state, and varies individually. Resting metabolic rate is affected by many factors. The aim of this study was to investigate whether resting metabolic rate changes depending on the blood groups. Materials and Methods: A total of 185 females and 37 males aged between 17 and 72 years who were admitted to our outpatient clinic due to obesity were evaluated with bare feet in length. Weight, body mass index (BMI), fat percentage, fat mass, and fat free mass were determined by a bioimpedance device (Tanita-BC418). Resting metabolic rate was detected by a fitmate device. Calorimetric measurement method was used to measure resting metabolic rates (RMR). ABO and Rh blood groups were determined via Microplack method as Forward Reverse.Results: There was not any significant difference according to ABO blood groups in terms of age, gender, body weight, fat percentage (F%), fat mass (FM) fat free mass (FFM), fat mass index (FMI) and fat free mass index (FFMI). There was not any statistically significant difference for RMR, RMR% measurements according to ABO blood groups and Rh factor (p>0.05).Conclusion: Resting metabolic rate did not change according to the ABO blood groups and Rh factor in obese individuals. Since blood group antigens are variable parameters according to individuals, we did not find any meaningful finding in this study based on whether this variability has an effect on resting metabolic rate.

PDF

___

1. Tataranni PA, Harper IT, Snitker S, et al. Body weight gain in free-living Pima Indians: effect of energy intake vs expenditure. Int J Obes Relat Metab Disord 2003;27:1578-83.
2. Sabounchi NS, Rahmandad H, Ammerman A. Bestfitting prediction equations for basal metabolic rate: Informing obesity interventions in diverse populations. Int J Obes (Lond) 2013;37:1364-70.
3. Bosy-Westphal A, Wolf A, Buhrens F, et al. Familial influences and obesity-associated metabolic risk factors contribute to the variation in resting energy expenditure: the Kiel obesity prevention study. Am J Clin Nutr 2008;87:1695-701.
4. Wouters-Adriaens MP, Westerterp KR. Low resting energy expenditure in Asians can be attributed to body composition. Obesity (Silver Spring) 2008;16:2212-6.
5. Doucet E, St Pierre S, Alméras N, et al. Changes in energy energy-expenditure and substrate oxidation resulting from weight loss in obese men and women: is there an important contribution of leptin? J Clin Endocrinol Metab 2000;85:1550-6.
6. López M, Alvarez CV, Nogueiras R, et al. Energy balance regulation by thyroid hormones at central level. Trends Mol. Med 2013;19:418-27.
7. CowanFJ, Evans WD, Gregory JW. Metabolic effects of discontinuing growth hormone treatment Arch Dis Child 1999;80:517-23.
8. Illner K, Brinkmann G, Heller M, et al.Metabolically active components of fat free mass and resting energy expenditure in nonobese adults.Am. J. Physiol. Endocrinol. Metab 2000;278:308-15.
9. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988;318:467-72 .
10. DeLany JP, Kelley DE, Hames KC, et al. High energy expenditure masks low physical activity in obesity. Int J Obes (Lond) 2013;37:1006-11.
11. Stiegler P, Cunliffe A.The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss. Sports Med 2006;36:239-62.
12. Müller MJ, Bosy-Westphal A, Kutzner D, et al. Metabolically active component of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies. Obes Rev 2002;3:113-22.
13. Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:1280-5.
14. Fry AE, Griffiths MJ, Auburn S, et al.Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 2007;17:567-76.
15. Chen Y, Chen C, Ke X, et al.Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ Cardiovasc Genet 2014;7:43-8.
16. Eren C, Cecen S. An Analysis on the Association Between ABO and Rh Blood Groups with Obesity. Proceedings of the National Academy of Sciences 2019;89:1095-100.
17. Weır B. New methods for calculatıng metabolic rate wıth specıal reference to proteın metabolısm. J. Physiol 1949;109:1-9.
18. Weyer C, Snitker S, Rising R, et al. Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int. J. Obes. Relat. Metab. Disord 1999;23:715-22.
19. Owen OE, Smalley KJ, D'Alessio DA, et al.Resting metabolic rate and body composition of achondroplastic dwarfs. Med 1990;69:56-67.
20. Astrup A, Buemann B. Low resting metabolic rate in subjects predisposed to obesity. A Role for Thyroid Status. Am J Clin Nutr 1996;63:879-83.
21. Sparti A, DeLany JP, de la Bretonne JA, et al.. Relationship between resting metabolic rate and the composition of the fat-free mass. Metabolsim 1997; 46:1225-30.
22. Ravussin E, C. Bogardus.Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr 1989;49:968-75.
23. Cecen S, Eren C. The association between ABO, RH blood types and eating behaviour. Medeniyet Medical J 2018;33:314-9.
24. Chandra T, Gupta A. Association and distribution of hypertension, obesity and ABO blood group in blood donors. Iran J Pediatr Hematol Oncol 2012;2:140-5.
25. Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 2013;11:491-9.
26. Garratty G. Blood groups and disease: a historical perspective. Transfus Med Rev 2000;14:291-301.
27. Watkins WM. The ABO blood group system: historical background. Transfus Med 2001;11:243-65.
28. Karadag A. Comparison of distribution of blood groups in inflammatory rheumatic diseases and healthy subjects. Cumhuriyet Tıp Dergisi 2019:41:516-23.
29. Sparks Jeffrey A, Costenbader Karen H. Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases. Rheum Dis Clin North Am 2014;40:637-57.
30. Seyfizadeh N, Seyfizadeh N, Negahdar H, et al. ABO Blood Group and Prevalence of Osteoporosis and Osteopenia in the Elderly Population: An Amirkola Health and Ageing Project (AHAP)-Based Study. J Clin Densitom 2018;21:200-4.
31. Choi JW, Pai S. H.Associations between ABO blood groups and osteoporosis in postmenopausal women. Ann Clin Lab Sci 2004;34:150-3.
32. Colier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporozis associated with chronic liver disease. Gut 2002;50:11-9 .
33. Meo SA, Rouq FA, Suraya F, et al. Association of ABO and Rh Blood Groups With Type 2 Diabetes Mellitus. Eur Rev Med Pharmacol Sci 2016;20:237-42.
34. Pare G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM- 1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008;4:e1000118.
35. Imberty A, Varrot A. Microbial recognition of human cell surface glycoconjugates. Curr Opin Struct Biol 2008;18:567-76.
36. Grundy SM, Brewer Jr HB, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
37. Klein HG, Anstee DJ, Mollison’s blood transfusion in clinicalmedicine, 11th ed, Oxford: Blackwell Publishing 2005;496-545.
38. Huang CH, Ye M. The Rh protein family: gene evolution, membrane biology, and disease association. Cell Mol Life Sci 2010;67:1203-18.
39. Aflatoonian MR, Meymandi MS, Divsalar K, et al. Possible association between human blood types and opioid addiction. Am J Addict 2011;20:581-4.